Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Kathryn L McElhinney und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fertility & Hormone Preservation & Restoration Program, Division of Pediatric Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago,…. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, Gesualdo Foundation Research Scholar, National Institutes of Health's National Center for Advancing Translational Sciences.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Treatment for certain childhood cancers and nonmalignant conditions can lead to future infertility and gonadal failure. The risk of treatment delay must be considered when offering fertility preservation (FP) options. We examined the timeline from FP referral to return to treatment (RTT) in pediatric patients who underwent FP due to iatrogenic risk for infertility.
Methods
A retrospective review was performed of patients with FP consultation due to an increased risk of iatrogenic infertility at Ann & Robert H. Lurie Children's Hospital of Chicago from 2018 to 2022. Data on diagnosis, age, treatment characteristics, and procedure were collected.
Results
A total of 337 patients ( n = 149 with ovaries, n = 188 with testes) had an FP consultation. Of patients with ovaries, 106 (71.1%) underwent ovarian tissue cryopreservation (OTC), 10 (6.7%) completed ovarian stimulation/egg retrieval (OSER), and 33 (22.1%) declined FP. Of the patients with testes, 98 (52.1%) underwent testicular tissue cryopreservation (TTC), 48 (25.5%) completed sperm banking (SB), and 42 (22.3%) declined FP. Median time from referral to FP consultation was short (ovaries: 2 days, range: 0–6; testes: 1 day, range: 0–5). OSER had a significantly longer RTT versus OTC and no FP (52.5 vs.19.5 vs. 12 days, p = .01). SB had a significantly quicker RTT compared to TTC or no FP (9.0 vs. 21.0 vs. 13.5 days; p = .008). For patients who underwent OTC/TTC and those who declined FP, there was no significant difference in time from consultation to treatment.
Conclusions
It is feasible to promptly offer and complete FP with minimal delay to disease‐directed treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fertility & Hormone Preservation & Restoration Program, Division of Pediatric Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Division of Pediatric Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Division of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Division of Endocrinology, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: Kathryn L McElhinney
Förderung
- NCATS NIH HHS
- Gesualdo Foundation Research Scholar
- National Institutes of Health's National Center for Advancing Translational Sciences
Zitieren
APA
McElhinney, K. L., McLean, S. K., Zarnegar-Lumley, S., Laronda, M. M., & Rowell, E. E. (2024). Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31232
Vancouver
McElhinney KL, McLean SK, Zarnegar-Lumley S, Laronda MM, Rowell EE. Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31232
BibTeX
@article{McElhinney2024,
author = {McElhinney, Kathryn L and McLean, Samantha K and Zarnegar-Lumley, Sara and Laronda, Monica M and Rowell, Erin E},
title = {Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31232}
}
EUVIMED